Melbourne, United Kingdom

David Hugh Williams

This inventor holds 7 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 10 EPO patents. Top assignees: Cancer Research Technology Limited, Discuva Limited, Mast Group Limited. Active years: 2011-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Hugh Williams. Retrieved from https://idiyas.com/inventor/david-hugh-williams-4h3onv3n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 71.4

 

 

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 47(Granted Patents)


Location History:

  • Cambridge, GB (2013 - 2017)
  • Liverpool, GB (2021)
  • Melbourn, GB (2011 - 2022)

Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **David Hugh Williams: A Pioneer in Antibiotic Research**

Introduction

David Hugh Williams, an accomplished inventor based in Melbourn, GB, holds a remarkable portfolio of six patents. His work primarily focuses on methods related to identifying antibiotic targets, with significant implications for advancing medical research and treatment.

Latest Patents

Among his latest patents, Williams has developed innovative methods for identifying essential genes that serve as antibiotic targets in bacteria. One notable patent details a process where a pool of mutant bacteria is generated through transposon mutagenesis, incorporating an activating transposon. This method allows for the identification of differentially represented genes by growing the mutant bacteria in varying antibiotic concentrations and comparing Tninsertions across different test cultures. His research is cutting-edge, aimed at overcoming challenges posed by antibiotic resistance.

Career Highlights

Throughout his career, David Hugh Williams has made significant contributions to the field of antibiotic research. He has worked with esteemed organizations such as Cancer Research Technology Limited and Discuva Limited, playing a vital role in pushing the boundaries of scientific knowledge and application in the life sciences sector.

Collaborations

Williams has collaborated with notable colleagues in the field, including Ian James Collins and John Charles Reader. These partnerships have fostered collaborative innovations, driving forward the shared goal of enhancing antibiotic effectiveness and understanding bacterial genetics.

Conclusion

David Hugh Williams stands out as a key figure in the realm of antibiotic research, with his patents reflecting a commitment to innovation and scientific advancement. His work not only illuminates the complexities of bacterial genetics but also paves the way for future developments in antibiotic therapies, aiming to make a lasting impact on global health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…